CD274 and myeloid sarcoma: While in the context of acute treatment paradigms this effect may be largely mediated through altered T cell responses, we show that blockade of PD-L1 during late-stage autoimmune CNS inflammation and a model of chronic MS drives the pathogenic activities of astrocytes and microglia.